bradykinin, des-arg(9)- has been researched along with Invasiveness, Neoplasm in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhoola, KD; Borquez, C; Ehrenfeld, P; Figueroa, CD; Lizama, A; Manso, L; Matus, CE; Naran, A; Pavicic, MF; Poblete, MT; Sarmiento, J | 1 |
Daaka, Y; Guo, R; Leeb-Lundberg, LM; Madden, JF; Taub, JS | 1 |
2 other study(ies) available for bradykinin, des-arg(9)- and Invasiveness, Neoplasm
Article | Year |
---|---|
Bioregulation of kallikrein-related peptidases 6, 10 and 11 by the kinin B₁ receptor in breast cancer cells.
Topics: Bradykinin; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Female; Humans; Kallidin; Kallikreins; Kininogens; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; MCF-7 Cells; Neoplasm Invasiveness; Receptor, Bradykinin B1; RNA Interference; RNA, Small Interfering; Serine Endopeptidases; Tissue Kallikreins; Up-Regulation | 2014 |
Bradykinin receptor subtype 1 expression and function in prostate cancer.
Topics: Biopsy; Bradykinin; Bradykinin Receptor Antagonists; Cell Division; Cell Movement; Enzyme Activation; Humans; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Prostatic Neoplasms; Receptors, Bradykinin; Signal Transduction | 2003 |